UK markets closed

4basebio PLC (4BB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,070.00-50.00 (-4.46%)
At close: 02:43PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 143.42M
Enterprise value 142.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)389.73
Price/book (mrq)42.05
Enterprise value/revenue 402.31
Enterprise value/EBITDA -22.37

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 375.00%
S&P500 52-week change 321.08%
52-week high 31,120.00
52-week low 3492.00
50-day moving average 3920.70
200-day moving average 3684.17

Share statistics

Avg vol (3-month) 32.97k
Avg vol (10-day) 32.02k
Shares outstanding 512.81M
Implied shares outstanding 612.81M
Float 84.21M
% held by insiders 162.19%
% held by institutions 19.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,581.51%

Management effectiveness

Return on assets (ttm)-35.08%
Return on equity (ttm)-97.29%

Income statement

Revenue (ttm)354k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)56.60%
Gross profit (ttm)N/A
EBITDA -6.36M
Net income avi to common (ttm)-6.28M
Diluted EPS (ttm)-0.51
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.56M
Total cash per share (mrq)0.29
Total debt (mrq)6.87M
Total debt/equity (mrq)201.47%
Current ratio (mrq)3.41
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-5.22M
Levered free cash flow (ttm)-5.2M